grey market retatrutide forum Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Stung by high prices, Americans

Amgens MariTide, currently in Phase 3 trials, is being watched closely for its potential once-monthly or even once-quarterly dosing

It copies a natural gut hormone that increases insulin release, slows stomach emptying and signals fullness to the brain

[1] [2] According to the UK Summary of Product Characteristics (SmPC), increased urination (polyuria) is not listed as a recognised adverse effect of Ozempic

Summary: Retatrutide phase 2 trial data in type 2 diabetes showed dose-dependent weight loss of up to approximately 16.9% from baseline at 24 weeks with the 12 mg dose, alongside substantial HbA1c reductions

Track this item and get notified if the price drops